3 consecutive boards of Kunyao Health: The company's business does not involve the registration and production of health food. The sales of AKK bacterial powder currently have a minimal impact on the company's profits.

JY Health issues a risk warning announcement. After self-inspection, the company's current business does not involve the research, application, production, and sale of drugs, nor does it involve the registration and production of health food. All related strains and products are ordinary food raw materials or ordinary food. The research data at different stages are only basic experimental results and do not constitute product efficacy promises or health or drug qualification recognition. Subsidiary JY Ruying AKK Bacteria focuses on metabolism and weight management. Currently in the animal and clinical research plan initiation stage, the overall work is not yet completed. The related products are ordinary food raw materials and end products, and the phase research data have limitations. The general applicability awaits further verification through larger-scale market practice. The sale of AKK bacteria powder currently has minimal impact on the company's profit. The competition in the weight management functional food market is fierce. There is significant uncertainty as to whether AKK-related products can achieve market promotion at scale in the future, as well as whether they can generate stable sales revenue and profit contributions. Investors are advised to make careful decisions and pay attention to investment risks.